Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of YHP2406 and YHR2501 in Healthy Subjects
NCT07265167Phase 1Completed
- Sponsor
- Yuhan
- Start
- Oct 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP2406 (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve and Maximum plasma concentration. Started Oct 2025; status: completed.
02
Drugs
YHP2406
Beyond the preview
Go deeper on NCT07265167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265167.